-
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Given Consensus Rating of "Buy" by Analysts
来源: Buzz FX / 07 11月 2024 01:51:16 America/New_York
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Given Consensus Rating of "Buy" by Analysts Written by MarketBeat November 7, 2024 Share Link copied to clipboard. Shares of Dianthus Therapeutics, Inc. ( NASDAQ:DNTH - Get Free Report ) have earned
Read more...